Shares of Aerie Pharmaceuticals Inc. (AERI), a revenue-generating ophthalmic pharmaceutical company, are up more than 10%, following better-than-expected revenue for the fourth quarter and full-year ended December 31, 2019.
from RTT - Earnings https://ift.tt/2PezbbJ
via IFTTT
No comments:
Post a Comment